Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Needle-free monitoring of glucose and blood pressure

Hello,

Continuous monitoring of blood glucose and blood pressure is a burden for many patients. MediSensonic’s innovations may soon change that. The company is developing needle-free, non-invasive devices based on microwave technology to measure glucose and blood pressure levels. These solutions promise accurate, pain-free diagnostics that can make daily life significantly easier for people living with chronic diseases.

As the first feature in our new series “Meet the Makers” we show how MediSensonic’s technologies are already being applied – and what real-world benefits they offer for patients and care providers alike.

Enjoy reading!

Your MEDICA editorial team

Meet Health.

Image:Mammogram comparison showing ground truth (GT) and AI prediction (Pred) with marked regions highlighting potential anomalies; Copyright: Q.Lin, W.-M.Tan, J-Y. Ge et al.

Smarter mammography with AI support

Microcalcifications in mammograms are early indicators of breast cancer, but they can be difficult to detect. A new deep learning system now supports radiologists by identifying these subtle structures more precisely and consistently – regardless of device type or patient characteristics. The result: earlier detection, fewer false positives, and more efficient diagnostics.
Image: Two virtual scenes, each depicting a test subject in a cabin; Coopyright Weiß, Krop et al, Computers in Human Behavior, 2025

Virtual companions for real anxiety

At the start-up Renata Hawrylik of MediSensonic SA and her coworkers are developing a needle-free solution for continuous blood pressure and glucose monitoring. Their focus is not only on technological precision, but above all on everyday usability.

Meet Future.

Portrait of Renata Hawrylik with quote: “MedTech start-ups should be guided by the usability of their technology.” - MEDICA start-ups in focus.
At the start-up MediSensonic SA, Renata Hawrylik and her coworkers are developing a needle-free solution for continuous blood pressure and glucose monitoring. Their focus is not only on technological precision, but above all on everyday usability.
Banner with the words "Meet Health. Future. People.“ and ”November 17-20, 2025“; Copyright: Messe Düsseldorf

You like our newsletter? Then recommend us!

Forward this newsletter or the link https://www.medica-tradefair.com/newsletter_en to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to medica-redaktion@messe-duesseldorf.de.

Banner with the words "Follow us" and social media icons
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.